Abstract A127: A novel Integrin beta-6-targeted antibody-drug conjugate featuring a topoisomerase I inhibitor, PBX-004 with potent antitumor activity in multiple preclinical solid tumor models
Year: 2025
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Language: English
Subfield: Immunology and Allergy
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4415444392
